Apixaban - Latest Advances

Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzo.

Journal: Hospital pharmacy

Published: October 20, 2025

Recurrent Ischaemic Stroke in a Patient With Left Ventricular Thrombus Despite Apixaban: Successful Transition to Warfarin.

Journal: Cureus

Published: October 15, 2025

Impact of Pharmacy Student-Led Medication Counseling for New Start Anticoagulants on Patient Outcomes and Healthcare Utilization.

Journal: Innovations in pharmacy

Published: October 13, 2025

Spontaneous Pleural, Pericardial, and Intracranial Hemorrhages in a Patient with End-Stage Kidney Disease Receiving Apixaban: A Case Report.

Journal: The American journal of case reports

Published: October 12, 2025

Salmonella-Induced Immunothrombosis: An Unusual Case of Pulmonary Embolism in the Setting of Enteric Infection.

Journal: Cureus

Published: October 10, 2025

Spontaneous Regression of Rosai-Dorfman Disease Presenting as a Thigh Mass With Vascular Involvement: A Case Report.

Journal: Journal of investigative medicine high impact case reports

Published: October 09, 2025

Anticoagulant Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: September 30, 2025

B2Pin2-enabled reductive thioesterification of aryl triflates with thiocarbonates.

Journal: Chemical communications (Cambridge, England)

Published: September 30, 2025

Four-Factor Prothrombin Complex Concentrate Administration Timing in Oral Anticoagulant-Associated Intracranial Hemorrhage.

Journal: Hospital pharmacy

Published: September 29, 2025

Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy.

Journal: Cureus

Published: September 29, 2025

Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach.

Journal: Expert opinion on drug metabolism & toxicology

Published: September 29, 2025

Filters

Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzo.

Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzo.

Recurrent Ischaemic Stroke in a Patient With Left Ventricular Thrombus Despite Apixaban: Successful Transition to Warfarin.

Recurrent Ischaemic Stroke in a Patient With Left Ventricular Thrombus Despite Apixaban: Successful Transition to Warfarin.

Impact of Pharmacy Student-Led Medication Counseling for New Start Anticoagulants on Patient Outcomes and Healthcare Utilization.

Impact of Pharmacy Student-Led Medication Counseling for New Start Anticoagulants on Patient Outcomes and Healthcare Utilization.

Spontaneous Pleural, Pericardial, and Intracranial Hemorrhages in a Patient with End-Stage Kidney Disease Receiving Apixaban: A Case Report.

Spontaneous Pleural, Pericardial, and Intracranial Hemorrhages in a Patient with End-Stage Kidney Disease Receiving Apixaban: A Case Report.

Salmonella-Induced Immunothrombosis: An Unusual Case of Pulmonary Embolism in the Setting of Enteric Infection.

Salmonella-Induced Immunothrombosis: An Unusual Case of Pulmonary Embolism in the Setting of Enteric Infection.

Spontaneous Regression of Rosai-Dorfman Disease Presenting as a Thigh Mass With Vascular Involvement: A Case Report.

Spontaneous Regression of Rosai-Dorfman Disease Presenting as a Thigh Mass With Vascular Involvement: A Case Report.

Anticoagulant Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial.

Anticoagulant Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial.

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

Effect of Direct Oral Anticoagulants Versus Traditional Anticoagulation in Budd-Chiari Syndrome.

B2Pin2-enabled reductive thioesterification of aryl triflates with thiocarbonates.

B2Pin2-enabled reductive thioesterification of aryl triflates with thiocarbonates.

Four-Factor Prothrombin Complex Concentrate Administration Timing in Oral Anticoagulant-Associated Intracranial Hemorrhage.

Four-Factor Prothrombin Complex Concentrate Administration Timing in Oral Anticoagulant-Associated Intracranial Hemorrhage.

Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy.

Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy.

Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach.

Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach.